Evidence map›Paper›PMID 37381698›Full record

ArticleCNS neuroscience & therapeutics2023

Therapeutic role of mesenchymal stem cell-derived extracellular vesicles in neuroinflammation and cognitive dysfunctions induced by binge-like ethanol treatment in adolescent mice.

Susana Mellado, Carlos M Cuesta, Sandra Montagud, Marta Rodríguez-Arias, Victoria Moreno-Manzano, Consuelo Guerri, María Pascual

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Susana MelladoDepartment of Physiology, School of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Carlos M CuestaDepartment of Physiology, School of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Sandra MontagudDepartment of Psychobiology, Facultad de Psicología, Universitat de Valencia, Valencia, Spain.
Marta Rodríguez-AriasDepartment of Psychobiology, Facultad de Psicología, Universitat de Valencia, Valencia, Spain.
Victoria Moreno-ManzanoNeuronal and Tissue Regeneration Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Consuelo GuerriPríncipe Felipe Research Center, Valencia, Spain.
María PascualDepartment of Physiology, School of Medicine and Dentistry, University of Valencia, Valencia, Spain.ORCID 0000-0003-1420-631X
Universitat de València · ESCentro de Investigacion Principe Felipe · ES

Funding

Generalitat Valenciana CIAICO/2021/203Generalitat Valenciana CIPROM/2021/080the Carlos III Institute RD16/0017/0004the Primary Addiction Care Research Network RD21/0009/0005the Spanish Ministry of Health 2018-I003the Spanish Ministry of Health 2019-I039
6 · The paper itself

Abstract

backgroundExtracellular vesicles (EVs) are heterogeneous membrane vesicles secreted by cells in extracellular spaces that play an important role in intercellular communication under both normal and pathological conditions. Mesenchymal stem cells (MSC) are anti-inflammatory and immunoregulatory cells capable of secreting EVs, which are considered promising molecules for treating immune, inflammatory, and degenerative diseases. Our previous studies demonstrate that, by activating innate immune receptors TLR4 (Toll-like receptor 4), binge-like ethanol exposure in adolescence causes neuroinflammation and neural damage.

aimsTo evaluate whether the intravenous administration of MSC-derived EVs is capable of reducing neuroinflammation, myelin and synaptic alterations, and the cognitive dysfunction induced by binge-like ethanol treatment in adolescent mice. MATERIALS &

methodsMSC-derived EVs obtained from adipose tissue were administered in the tail vein (50 microg/dose, one weekly dose) to female WT adolescent mice treated intermittently with ethanol (3.0 g/kg) during two weeks.

resultsMSC-derived EVs from adipose tissue ameliorate ethanol-induced up-regulation of inflammatory genes (e.g., COX-2, iNOS, MIP-1α, NF-κB, CX3CL1, and MCP-1) in the prefrontal cortex of adolescent mice. Notably, MSC-derived EVs also restore the myelin and synaptic derangements, and the memory and learning impairments, induced by ethanol treatment. Using cortical astroglial cells in culture, our results further confirm that MSC-derived EVs decrease inflammatory genes in ethanol-treated astroglial cells. This, in turn, confirms in vivo findings.

conclusionTaken together, these results provide the first evidence for the therapeutic potential of the MSC-derived EVs in the neuroimmune response and cognitive dysfunction induced by binge alcohol drinking in adolescence.

Indexed as

Cognitive DysfunctionExtracellular VesiclesMesenchymal Stem CellsAnimalsEthanolFemaleMiceMice, KnockoutNeuroinflammatory DiseasesEthanoladolescencebinge-like ethanol treatmentcognitive dysfunctionextracellular vesiclesmesenchymal stem cellsneuroinflammation

Identifiers

PMID37381698
PMCPMC10651955
OpenAlexW4382501792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.